T-Cell and NK-Cell Neoplasm — Trials

T-Cell and NK-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,103 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 51–100 of 400 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06511869	AZD4205 in Peripheral T Cell Lymphoma Following First-Line Therapy (JACKPOT26)	completed	Phase 2	48	Dizal PharmaceuticalsINDUSTRY	1	Jul 4, 2025	clinicaltrials
NCT00001337	Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma	completed	Phase 2	348	National Cancer Institute (NCI)NIH	1	Jun 22, 2025	clinicaltrials